HealthEquity/$HQY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About HealthEquity

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Ticker

$HQY
Sector
Primary listing

Employees

3,113

HealthEquity Metrics

BasicAdvanced
$8.4B
59.35
$1.65
0.50
-

What the Analysts think about HealthEquity

Analyst ratings (Buy, Hold, Sell) for HealthEquity stock.

Bulls say / Bears say

Strong Q1 FY26 results: revenue rose 15% YoY to $330.8 million and net income surged 87% to $53.9 million, fueling a 19% increase in adjusted EBITDA and leading management to raise full-year guidance (GlobeNewswire)
Rapid HSA growth fuels scale: the number of HSAs climbed 9% to 9.9 million and total HSA assets increased 15% to $31.3 billion, highlighting strong member acquisition and engagement (GlobeNewswire)
Share repurchases show confidence: HealthEquity bought back $60.3 million of its common stock in Q1 and has $117.5 million remaining under its repurchase authorization, demonstrating strong cash flow and a firm commitment to shareholders (HealthEquity IR)
Surging fraud costs dent profitability: Q4 FY25 service costs related to fraud escalated from $8 million to $17 million, reducing gross profit and leading to a 20% drop in the stock after missing earnings forecasts (Investopedia)
Elevated leverage post-acquisition: the $425 million BenefitWallet deal pushed long-term debt up to $1.06 billion from $875 million, increasing interest expense and financial risk (StockTitan)
Guidance offers limited upside: FY26 non-GAAP EPS guidance midpoint is slightly below consensus expectations, which may constrain analyst revisions and near-term investor sentiment (Investor’s Business Daily)
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.

HealthEquity Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HealthEquity Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HQY

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs